Publications by authors named "Marc Debled"

Claim this Profile
A
Association Between Daily Timing of Everolimus and Survival in High-Risk HR+/HER2- Early Breast Cancer: A Sub-Analysis of the UCBG-UNIRAD Trial.
Enora Laas, Anne-Sophie Hamy, Thomas Bachelot, Paul Gougis, Jérôme Lemonnier, Marc Debled

Clin Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of non-adherence to adjuvant letrozole using a population pharmacokinetics approach in hormone receptor-positive breast cancer patients.
Alicja Puszkiel, Florence Dalenc, Naïma Tafzi, Pierre Marquet, Marc Debled

Eur J Pharm Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trial.
Sylvie Giacchetti, Enora Laas, Thomas Bachelot, Jérome Lemonnier, Fabrice André, Marc Debled

EBioMedicine· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular features.
Hélène Salaün, Lounes Djerroudi, Laura Haik, Anne Schnitzler, Guillaume Bataillon, Marc Debled

J Pathol Clin Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of antiandrogens in androgen receptor-positive triple-negative metastatic breast cancer: Real-life data.
Yasmine Rhanine, Hervé Bonnefoi, Anthony Goncalves, Marc Debled, Sylvestre Le Moulec

Breast· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
Elie Rassy, Thomas Filleron, Alessandro Viansone, Magali Lacroix-Triki, Sofia Rivera, Marc Debled

Breast Cancer Res Treat· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database.
Audrey Mailliez, Veronique D'Hondt, Amelie Lusque, Olivier Caron, Luc Cabel, Marc Debled

Int J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort.
Laetitia Collet, Lauriane Eberst, Gauthier Ludovic, Marc Debled, Loana Hrab

Breast Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.
Hélène François-Martin, Audrey Lardy-Cléaud, Barbara Pistilli, Christelle Levy, Véronique Diéras, Marc Debled

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME Cohort.
Judicaël Hotton, Amélie Lusque, Léa Leufflen, Mario Campone, Christelle Levy, Marc Debled

Ann Surg· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes.
Marcela Carausu, Matthieu Carton, Véronique Diéras, Thierry Petit, Séverine Guiu, Marc Debled

JAMA Netw Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.
Thomas Bachelot, Paul Cottu, Sylvie Chabaud, Florence Dalenc, Djelila Allouache, Marc Debled

J Clin Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study.
Antoine Vasseur, Matthieu Carton, Severine Guiu, Paule Augereau, Lionel Uwer, Marc Debled

Breast· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy and radiotherapy for locally advanced breast cancer: Safety and efficacy of reverse sequence compared to standard technique?
Mathilde Maire, Marc Debled, Adeline Petit, Marion Fournier, Gaëtan Macgrogan

Eur J Surg Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas.
Natalie Jones, Audrey Gros, Valérie Velasco, Valérie Dapremont, Véronique Brouste, Marc Debled

Cancer Genet· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort.
Fabien Moinard-Butot, Caroline Saint-Martin, Carole Pflumio, Matthieu Carton, William Jacot, Marc Debled

Breast· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy and clinical impact of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in Positron Emission Tomography - Computed Tomography (PET-CT)-positive mediastinal lymphadenopathies in patients with thoracic or extra-thoracic malignancies.
Dominique Béchade, Carine Bellera, Lisa Gauquelin, Isabelle Soubeyran, Pippa McKelvie-Sebileau, Marc Debled

Clin Res Hepatol Gastroenterol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort study.
Florence Dalenc, Amélie Lusque, Thibault De La Motte Rouge, Barbara Pistilli, Etienne Brain, Marc Debled

Eur J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database.
Marcela Carausu, Matthieu Carton, Luc Cabel, Anne Patsouris, Christelle Levy, Marc Debled

Ther Adv Med Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer.
Pauline Corbaux, Audrey Lardy-Cleaud, Marie Alexandre, Maxime Fontanilles, Christelle Lévy, Marc Debled

Breast Cancer Res Treat· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence of the management and prognosis of young women (⩽40 years) with metastatic breast cancer.
Amélie Mallet, Amélie Lusque, Christelle Levy, Barbara Pistilli, Etienne Brain, Marc Debled

Ther Adv Med Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer.
Amanda Bortolini Silveira, François-Clément Bidard, Marie-Laure Tanguy, Elodie Girard, Olivier Trédan, Marc Debled

NPJ Breast Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of body mass index on overall survival in patients with metastatic breast cancer.
Khalil Saleh, Matthieu Carton, Véronique Dieras, Pierre-Etienne Heudel, Etienne Brain, Marc Debled

Breast· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial.
Thomas Bachelot, Thomas Filleron, Ivan Bieche, Monica Arnedos, Mario Campone, Marc Debled

Nat Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy-A Message from COMET, a French Unicancer Multicentric Study.
Jocelyn Gal, Gérard Milano, Patrick Brest, Nathalie Ebran, Julia Gilhodes, Marc Debled

Pharmaceuticals (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis